Company: INTS
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001567264-25-000077
Chunk: 10

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part II, Item 1A
Chunk 10
---
 XBRL and contained in Exhibit 101).

______________________________________

*   Filed herewith.

** Furnished herewith.

# Indicates a management contract or compensatory plan or arrangement.

25

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

Intensity Therapeutics, Inc.Date: August 7, 2025By:/s/ Lewis H. BenderLewis H. BenderPresident, Chief Executive Officer and Chairman

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.

NameTitleDate/s/ Lewis H. BenderPresident, Chief Executive Officer and ChairmanAugust 7, 2025Lewis H. Bender(principal executive officer)/s/ Joseph TalamoChief Financial OfficerAugust 7, 2025Joseph Talamo(principal financial officer)

26